Real-World data on acalabrutinib for CLL: what happens outside the lab?

NCT ID NCT06170671

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how well the drug acalabrutinib works for people with chronic lymphocytic leukemia (CLL) in real-life settings in Romania. Researchers will collect data from 250 patients over three years to see how long they stay on the drug, why they stop, and how effective it is. The goal is to understand the drug's performance outside of strict clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
acalabrutinib
What this could lead to
If successful, this study could provide valuable insights into how acalabrutinib performs outside of clinical trials, helping doctors make better treatment decisions for CLL patients.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection and real-world factors, and the study is limited to Romania.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    Piteşti, Argeş, 110084, Romania

  • Research Site

    Oradea, Bihor County, 410469, Romania

  • Research Site

    Cluj-Napoca, Cluj, 400015, Romania

  • Research Site

    Craiova, Dolj, 200143, Romania

  • Research Site

    Deva, Hunedoara County, 330084, Romania

  • Research Site

    Baia Mare, Maramureş, 430031, Romania

  • Research Site

    Târgu Mureş, Mureș County, 540136, Romania

  • Research Site

    Piatra Neamţ, Neamț County, 610136, Romania

  • Research Site

    Timișoara, Timiș County, 300239, Romania

  • Research Site

    Timișoara, Timiș County, 300254, Romania

  • Research Site

    Focşani, Vrancea, 620034, Romania

  • Research Site

    Brasov, 500052, Romania

  • Research Site

    Bucharest, 20125, Romania

  • Research Site

    Bucharest, 22328, Romania

  • Research Site

    Bucharest, 301710, Romania

  • Research Site

    Bucharest, 30171, Romania

  • Research Site

    Bucharest, 50098, Romania

  • Research Site

    Galati, 800578, Romania

  • Research Site

    Iași, 700483, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.